interference: search

Alnylam, Novartis Extend RNA Interference Collaboration

Alnylam Pharmaceuticals, the developer of drugs using RNA interference technology, said today that Switzerland-based pharmaceutical company Novartis has chosen to extend their RNAi collaboration another year, through October 2009. The partnership, worth as much as $700 million to Alnylam if certain development milestones are met, was first struck in 2005. Under the deal, Novartis (NYSE: NVS) retains rights to buy as much as 19.9 percent of Alnylam’s stock (NASDAQ: ALNY) and it currently owns a 13.4 percent stake, Alnylam said.

Silence Therapeutics Announces Successful Opposition of Glover Patent

a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety. The Opposition Division of the European Patent Office, following a three day hearing, announced its decision to revoke European Patent EP 1 230 375, exclusively licensed to Alnylam Pharmaceuticals from Cancer Research Technology, Ltd (UK). The Patent, commonly referred to as the "Glover" patent, broadly relates to medicaments comprising an RNA interference mediating RNA molecule. Opposition briefs to the Glover patent had been filed by Silence Therapeutics AG, Sanofi-Aventis Deutschland GmbH, Quark Biotech, Inc.

Handheld Real-Time Spectrum Analyzer for Digital RF Troubleshooting

Your Bluetooth design is due out the door, but it’s acting strangely. The hopping channels keep changing erratically as if your adaptive frequency hopping spread spectrum (FHSS) device is trying to avoid some sporadic interference. Is it a bug or just interference? With a new hop every 625 μsec and a hop time of just 359 μsec at 2.4 GHz, the chances of your traditional spectrum analyzer catching a sporadic interferer in a timely manner are close to zero.

Scientists Pave Way For 25nm CPUs

arcticstoat writes in with word that scientists at the Space Nanotechnology Laboratory at MIT have found a new way of extending Moore's law into the future — they have succeeded in etching a grid of 25nm lines into a silicon wafer. The article notes that this technique could be used for writing the grid on which chips are laid down, but that the electronic elements would have to be written using more complex techniques. "[Researchers] created an interference pattern using light from a laser with a wavelength of 351 nm. The pattern consists of alternating light and dark zones repeating every 200 nm. This allowed them to etch 25-nm lines into a silicon wafer, each 175 nm apart. They then repeated the process three times, each time shifting the interference pattern by 50 nm and etching another 25-nm groove.

RNA Interference and Plant Defenses

AAAS members activate your FREE subscription to ALL Science content since 1880, as well as ScienceNOW, the SAGE KE Archive and AAASMember.org.

[PERSPECTIVES] MOLECULAR BIOLOGY: RNA Interference in the Nucleus

Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.

EFF Releases Tool For Testing ISP Interference

Broadband Service Provider Trident SR Sdn. Bhd.

EFF Offers New Tool To Test ISP Interference - New open source, command line software dubbed Switzerland

Broadband Service Provider Trident SR Sdn. Bhd.

FCC to test proposed free wireless service for interference

Federal Communications Commission engineers will be conducting tests in Seattle next week to see if a proposed free wireless service would interfere with T-Mobile's newly acquired spectrum.

Scientists identify antibiotics to enhance gene-silencing tool

A class of antibiotics, known as fluoroquinolones can enhance RNA interference, the gene-silencing tool that can treat a variety of diseases if adapted in humans, say researchers at Emory University.

Silence Therapeutics Announces Successful Opposition of Glover Patent

Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety.

::: Silence Therapeutics Announces Successful Opposition of Glover Patent

London, UK, 11 July 2008 – Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety.

SILENCE THERAPEUTICS PLC - Statement re Successful Patent Opposition

London, UK, 11 July 2008 - Silence Therapeutics plc (London AIM: SLN), a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceticals, Inc. European patent resulting in the patent being revoked in its entirety.

Half of digital photo frames fail BSMI test

TAIPEI, Taiwan -- Half of the digital photo frames sampled on the market failed the electromagnetic interference test, according to the Bureau of Standards, Metrology and Inspection (BSMI) under the Ministry of Economic Affairs yesterday.

Benitec receives RNAi patent in New Zealand

Benitec Limited announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA interference (RNAi) was granted in New Zealand.

Alnylam Loses RNAi Patent in Europe; Analyst Says No Worries

Alnylam Pharmaceuticals (NASDAQ: ALNY) isn’t used to losing patent cases, but it happened yesterday in Europe to one of the company’s RNA interference patents, known as Glover. The company said it plans to appeal.

Silego Technology, Inc. Launches Patent Pending EMI Reduction Spread Spectrum Clock Generator with FrequencyAware(TM)

Silego Technology, Inc. an industry leader in timing generators recently broadened its product offering to include a complete line of low power, low jitter EMI (Electro-magnetic Interference) reduction spread spectrum clock generators (SSCG). Today Silego launched a new type of SSCG featuring FrequencyAware

Has Google turned from cool into corporate Death Star? Part 2

Many within the technology industry are unwilling to call on government to clip its wings because it goes against their faith in an open Internet, free of state interference.¡¦

White Space tests get mixed results

Field tests to determine whether the Federal Communications Commission should open up unused TV spectrum for wireless broadband services are getting mixed reviews as different methods for avoiding spectrum interference are being tested in the real world.

Three DVDs of rhymes out on stands

MADURAI: Now, be it rhymes or lessons, everything is available in CD and DVD formats. In fact, the CDs and DVDs allow the children learn by themselves without parents’ interference.

Silego Technology, Inc. Launches Patent Pending EMI Reduction Spread Spectrum Clock Generator with FrequencyAware(TM)

SANTA CLARA, Calif., BUSINESS WIRE -- Silego Technology, Inc. an industry leader in timing generators recently broadened its product offering to include a complete line of low power, low jitter EMI (Electro-magnetic Interference) reduction spread spectrum clock generators (SSCG). Today Silego launched a new type of SSCG featuring FrequencyAware(TM).

Silego Technology, Inc. Launches Patent Pending EMI Reduction Spread Spectrum Clock Generator with FrequencyAware(TM)

SANTA CLARA, Calif. - (Business Wire) Silego Technology, Inc. an industry leader in timing generators recently broadened its product offering to include a complete line of low power, low jitter EMI (Electro-magnetic Interference) reduction spread spectrum clock generators (SSCG). Today Silego launched a new type of SSCG featuring FrequencyAware

Benitec Limited (ASX:BLT) Announce Double-Stranded Patent Granted In New Zealand

http://www.abnnewswire. %20com/en>) - Benitec Limited (ASX:BLT)(PINK:BNIKF) today announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA interference (RNAi) was granted in New Zealand.

::: Benitec Limited (ASX:BLT) Announce Double-Stranded Patent Granted In New Zealand

Melbourne, Australia, Aug 8, 2008 - (ABN Newswire) - Benitec Limited (ASX:BLT)(PINK:BNIKF) today announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA interference (RNAi) was granted in New Zealand.

Benitec Limited (ASX:BLT) Announce Double-Stranded Patent Granted In New Zealand

2008-08-07Â 23:32Â ET - News Release Melbourne, Australia, Aug 8, 2008 - (ABN Newswire) - Benitec Limited (ASX:BLT)(PINK:BNIKF) today announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA interference (RNAi) was granted in New Zealand.

Search took 0.02 seconds.